Massie B M, Hirsch A T, Inouye I K, Tubau J F
Am J Med. 1984 Oct 5;77(4A):135-42. doi: 10.1016/s0002-9343(84)80049-2.
Because of their unique action on the cardiovascular system, the calcium channel blockers have generated a great deal of excitement among pharmacologists, physiologists, and clinicians. One obvious potential application for these drugs is in antihypertensive therapy and, although experience with these agents for this indication is limited in the United States, it is considerable in Europe and Japan. These agents' ultimate role in antihypertensive therapy, however, has not been established. Since the available calcium channel blockers are structurally diverse, it is uncertain whether they will have comparable effects in hypertension. The rationale for the use of calcium channel blockers in treating hypertension and the relevant pharmacologic actions of these agents is discussed, along with a summary of some of the clinical trials, observations from our own experience with these drugs, and speculation about their future role in antihypertensive therapy.
由于钙通道阻滞剂对心血管系统具有独特作用,它们在药理学家、生理学家和临床医生中引起了极大的关注。这些药物一个明显的潜在应用是用于抗高血压治疗,尽管在美国用于该适应症的经验有限,但在欧洲和日本却相当丰富。然而,这些药物在抗高血压治疗中的最终作用尚未确定。由于现有的钙通道阻滞剂在结构上各不相同,它们在高血压治疗中是否会产生类似的效果尚不确定。本文将讨论使用钙通道阻滞剂治疗高血压的理论依据以及这些药物的相关药理作用,同时总结一些临床试验、我们自身使用这些药物的经验观察结果,并推测它们在抗高血压治疗中的未来作用。